HomeCLSD • NASDAQ
add
Clearside Biomedical Inc
Previous close
$1.37
Day range
$1.29 - $1.45
Year range
$0.65 - $2.12
Market cap
100.13M USD
Avg Volume
415.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 6.34M | 1,822.73% |
Operating expense | 9.26M | 12.98% |
Net income | -4.83M | 49.99% |
Net profit margin | -76.15 | 97.40% |
Earnings per share | -0.08 | 50.00% |
EBITDA | -2.90M | 64.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 28.92M | -40.07% |
Total assets | 34.02M | -33.69% |
Total liabilities | 49.93M | 22.69% |
Total equity | -15.91M | — |
Shares outstanding | 74.72M | — |
Price to book | -5.48 | — |
Return on assets | -21.30% | — |
Return on capital | -26.01% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.83M | 49.99% |
Cash from operations | 495.00K | 108.83% |
Cash from investing | -120.00K | -31.87% |
Cash from financing | -257.00K | -144.70% |
Net change in cash | 118.00K | 102.30% |
Free cash flow | -533.00K | 87.50% |
About
Founded
2011
Headquarters
Website
Employees
30